Results 261 to 270 of about 85,906 (293)
Some of the next articles are maybe not open access.
Technetium-99m Diphosphonate Retention in Hyperparathyroidism
Annals of Internal Medicine, 1980Excerpt To the editor: Fogelman and colleagues (1) show increased total-body retention of technetium-99m diphosphonate in a small group of patients with primary hyperparathyroidism and equate this ...
openaire +2 more sources
Scintimammography with technetium-99m tetrofosmin
European Journal of Nuclear Medicine, 1996MANSI, Luigi, RAMBALDI PF
openaire +3 more sources
SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997Technetium-99m-HMPAO and 99mTc-ECD have been used for regional cerebral blood flow (rCBF) studies using SPECT. However, details of the normal perfusion patterns of these agents still remain to be clarified. HMPAO-SPECT and ECD-SPECT images of normal individuals were investigated using an anatomical standardization technique.Twenty healthy subjects ...
M, Koyama +9 more
openaire +1 more source
Addressing Technetium-99m Shortage
Journal of the American College of Radiology, 2017Mahadevappa Mahesh, Mark Madsen
openaire +2 more sources
The Radiopharmaceutical Chemistry of Technetium-99m
Radiopharmaceutical Chemistry, 2019S. Rathmann +5 more
semanticscholar +1 more source
Technetium-99m radiochemistry for pharmaceutical applications.
Journal of labelled compounds & radiopharmaceuticals, 2017D. Papagiannopoulou
semanticscholar +1 more source
Scanning the thyroid with technetium-99m-pertechnetate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992PubMed ID ...
Ozkilic, H, Derebek, E
openaire +2 more sources
Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997Technetium-99m-MIBI was initially developed for heart studies but it can also be used to depict tumors, predict multidrug resistance and evaluate chemotherapy. Recently, 99mTc-tetrofosmin, which exhibits similar physical properties, has been launched for heart studies.
V, Söderlund +4 more
openaire +1 more source
A review on evaluation of technetium-99m labeled radiopharmaceuticals
Journal of Radioanalytical and Nuclear Chemistry, 2016M. Akbar +3 more
semanticscholar +1 more source

